BMI decreased in all groups, with a highly significant reduction in the GLP‐1RA and SGLT‐2I cohorts (with differences also when compared with DPP‐4I‐treated patients).
← all excerpts
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis.
1
—
—